2015
Can routine cavity shave margins (CSM) improve local control in breast cancer? Initial results of the SHAVE trial, a prospective randomized controlled trial of routine CSM vs. standard partial mastectomy (SPM).
Chagpar A, Killelea B, Tsangaris T, Butler M, Stavris K, Yao X, Li F, Bossuyt V, Pusztai L, Horowitz N. Can routine cavity shave margins (CSM) improve local control in breast cancer? Initial results of the SHAVE trial, a prospective randomized controlled trial of routine CSM vs. standard partial mastectomy (SPM). Journal Of Clinical Oncology 2015, 33: 1012-1012. DOI: 10.1200/jco.2015.33.15_suppl.1012.Peer-Reviewed Original Research
2014
Does three-dimensional intraoperative specimen imaging reduce the need for re-excision in breast cancer patients?
Chagpar A, Butler M, Killelea B, Horowitz N, Stavris K, Lannin D. Does three-dimensional intraoperative specimen imaging reduce the need for re-excision in breast cancer patients? Journal Of Clinical Oncology 2014, 32: 107-107. DOI: 10.1200/jco.2014.32.30_suppl.107.Peer-Reviewed Original ResearchMargin statusIntraoperative imagingFinal margin statusMedian tumor sizeBreast cancer patientsRe-excision ratesIntraoperative specimen radiographyCohort of interestIntraoperative marginsResidual tumorPartial mastectomyPositive marginsProspective studyTumor sizeCancer patientsInvasive cancerFurther excisionPathology resultsIntraoperative resectionPatientsDefinitive specimenSpecimen radiographyIntraoperative specimenSurgeons
2013
SHAVE: A randomized controlled trial of routine shave margins versus standard partial mastectomy.
Chagpar A, Stavris K, Killelea B, Tsangaris T, Horowitz N. SHAVE: A randomized controlled trial of routine shave margins versus standard partial mastectomy. Journal Of Clinical Oncology 2013, 31: tps1145-tps1145. DOI: 10.1200/jco.2013.31.15_suppl.tps1145.Peer-Reviewed Original ResearchStandard partial mastectomyPositive margin ratePartial mastectomyRe-excision ratesShave marginsCosmetic outcomeMargin rateBreast cancerVolume of tissueCavity shave marginsNeoadjuvant chemotherapyPrimary endpointMastectomy groupLocal recurrenceOperative timeOutcome measuresStage 0Intraoperative timeMargin groupMost seriesPatientsMastectomyInformed consentAdditional tissueOperating room